International Patent: TREATMENT OF HYPERMUTATED SOLID TUMOR CANCERS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES

GENEVA, Sept. 7 -- IOVANCE BIOTHERAPEUTICS, INC. filed a patent application (US2026/016681) for “TREATMENT OF HYPERMUTATED SOLID TUMOR CANCERS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES”. With publication no. WO/2026/183237, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0783

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....